Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 320 results for "cadila pharma"

Cadila, Depomed Inc settle patent dispute
Business Standard India

Pharma duo settle patent row in US

(PTI): Cadila Healthcare and Zydus Pharmaceuticals today said they had entered into a settlement agreement with Depomed Inc in a patent infringement row. The case is related to Depomeds neuropathic pain relieving drug Gralise. Cadila Healthcare and Zydus ... The Telegraph, 4 days ago
Cadila, Zydus to settle patent infringement case, 4 days ago
Cadila, Depomed settle case on gapapentin Times of India, 4 days ago

30 images for cadila pharma, 3 weeks ago
Sify, 1 month ago, 1 month ago, 1 month ago
Financial Express, 3 months ago, 2 months ago
NDTV Profit, 3 months ago
NDTV Profit, 3 months ago
NDTV Profit, 3 months ago
Times of India, 2 months ago

Select pharma shares on a roll, Wockhardt zooms 20%

Wockhardt, Strides Arcolab and Ranbaxy Laboratories have rallied between 10-20%, while Aurobindo Pharma, Cadila Healthcare, Cipla, Biocon, Lupin and Divi's Laboratories are trading higher in the range of 2-6% on the BSE. The BSE pharmaceutical ...
 Smart Investor2 weeks ago Aurobindo up 6%, Lupin hits record high post Nomura report  Moneycontrol.com1 month ago Bullish on Cadila Pharma, Lupin, Sun Pharma: Hemang Jani, Sharekhan  Economic Times2 months ago

Panel rejects clinical trial applications by leading drug makers

Clears only 28 of 47 applications, Cadila Pharma, Wockhardt, Novartis and Roche among firms impacted Sushmi Dey | New Delhi March 31, 2014 Last Updated at 20:25 IST Proposals from leading pharmaceutical companies such as Novo Nordisk, Cadila ...
 Business Standard India2 weeks ago

GPCB issues closure notice to Zydus Cadila research unit

Gujarat Pollution Control Board (GPCB) has issued a closure notice to pharma major Zydus Cadila's research unit here for allegedly polluting ground water in its vicinity, a senior official said today. "We received a complaint from people that Zydus ...
 Business Standard1 month ago Zydus R&D unit served closure notice over pollution  Times of India1 month ago

Sensex up 72 points in early trade; Aurobindo Pharma, Cadila post strong gains

The Indian stock market is trading firm this morning, with investors indulging in some buying, tracking positive global cues. Bank, realty, power, information technology and consumer durables stocks are among the notable gainers. A few stocks from healthcare ...
 Sify1 month ago Sensex up 72 pts in early trade; Aurobindo Pharma, Cadila post strong gains  Sify1 month ago

Cadila Healthare shares surge nearly 6 pc on smart earnings

Shares of Cadila Healthcare today surged nearly 6 per cent after pharma firm reported 81.54 per cent increase in consolidated net profit for the third quarter ended December 31. Cadila's stock ended the day 5.85 per cent higher at Rs 903.15 on the ...
 Business Standard2 months ago

Pharmaceuticals Newsletter April 14 to 18, 2014

Glenmark has received from Sanofi already USD 50 Mn as an upfront payment in FY2011-12. Top News Glenmark Pharma receives US$5 mn as milestone payment from Sanofi has announced that the Company through its Swiss subsidiary has received US$5 mn as ...
 India Infoline19 hours ago

UBM India to organise 3rd Annual Global Pharma Regulatory Summit 2014

Event to be held in Mumbai from April 23 to 25, 2014 UBM India will organise a three-day strategic summit which will bring together US FDA, MHRA and Lachman consultants at the 3rd Annual Global Pharma Regulatory Summit to be held in Mumbai from ...
 Express Pharma1 day ago USFDA, MHRA and Lachman Consultants All Under One Roof at CPhI's 3rd Annual Global Pharma Regulatory Summit 2014  PR Newswire India4 days ago
The Freepress Journal

StatsGuru: 14-April-2014

Taking stock of the country's pharma sector Business Standard | New Delhi April 14, 2014 Last Updated at 00:02 IST The Indian pharma sector has been shaken up by the sale of Ranbaxy Laboratories to Sun Pharmaceutical Industries by Ranbaxy's ...
 Business Standard India6 days ago Sun-Baxy: Charity at home  Times of India6 days ago Experts say Indian pharma space ripe for consolidation  The Freepress Journal1 week ago How will Sun-Ranbaxy look like at the end of the story  VC Circle1 week ago

Karvy expects improvement in pharma cos' revenues for Q4

Source: IRIS (10-APR-14) Comments | Post Comment The domestic formulations market has been improving month-on-month and has shown a positive growth for the last couple of months. Select companies such as Sun, Lupin, Ipca, Alembic and Indoco will ...
 MyIris1 week ago Sensex up 69 pts amid cautious trades; Pharma stocks in demand  Sify1 month ago Sensex climbs 300 points to settle above 22,000  MyIris3 weeks ago Sensex gains 133 points to settle above 21,000  MyIris1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less